Results 21 to 30 of about 1,517,186 (231)

The effect of oral corticosteroids on bronchodilator responses in COPD [PDF]

, 1998
There have been suggestions that corticosteroid treatment might improve bronchodilator responses in chronic obstructive pulmonary disease (COPD). We have studied bronchodilator responses to salbutamol and to oxitropium bromide in 20 patients with stable ...
Rees, P.J., Corden, Z.
core   +1 more source

Oxygen versus air-driven nebulisers for exacerbations of chronic obstructive pulmonary disease: a randomised controlled trial

BMC Pulmonary Medicine, 2018
Background In exacerbations of chronic obstructive pulmonary disease, administration of high concentrations of oxygen may cause hypercapnia and increase mortality compared with oxygen titrated, if required, to achieve an oxygen saturation of 88–92 ...
George Bardsley, Janine Pilcher, Steven McKinstry, Philippa Shirtcliffe, James Berry, James Fingleton, Mark Weatherall, Richard Beasley   +7 more
doaj   +1 more source

Paediatrics: how to manage acute asthma exacerbations

Drugs in Context, 2021
Background: Asthma is the most common chronic disease of childhood and a major source of childhood health burden worldwide. These burdens are particularly marked when children experience characteristic ‘symptom flare-ups’ or acute asthma exacerbations ...
James S Leung
doaj   +1 more source

Combination therapy with indacaterol and glycopyrronium bromide in the management of COPD: an update on the evidence for efficacy and safety

Therapeutic Advances in Respiratory Disease, 2015
The international guidelines on chronic obstructive pulmonary disease (COPD) recommend inhaled bronchodilators for maintenance treatment of the disease. These drugs include β2-agonists and muscarinic antagonists, which are both available as short-acting ...
Erminia Ridolo, Marcello Montagni, Gian Galeazzo Riario-Sforza, Marco Baroni, Cristoforo Incorvaia   +4 more
doaj   +1 more source

Evaluation of the Comparative Efficacy of Dugdhika (Euphorbia prostrata W. Aiton) Inhalation versus Salbutamol in the Management of Tamaka Shwasa (Bronchial Asthma): A Research Protocol [PDF]

Journal of Clinical and Diagnostic Research
Introduction: Tamaka Shwasa is an Ayurvedic respiratory disorder caused by vitiated Prana Vayu and aggravated Kapha, often worsened by dust, smoke, cold, and exertion. It resembles bronchial asthma, which affects around 300 million people globally and 15-
Bhavesh Dangore, Sadhana Misar Wajpeyi
doaj   +1 more source

Randomised, double blind, placebo controlled study of fluticasone propionate in patients with moderate to severe chronic obstructive pulmonary disease: The ISOLDE trial [PDF]

, 2000
Objectives To determine the effect of long term inhaled corticosteroids on lung function, exacerbations, and health status in patients with moderate to severe chronic obstructive pulmonary disease.
Spencer, S, Spencer, Sally, Calverley, Peter MA, Jones, Paul W, Jones, PW, Maslen, TK, Burge, P Sherwood, Burge, PS, Calverley, PMA, Maslen, T K, Anderson, JA, Spencer, Sally; id_orcid, Anderson, Julie A   +12 more
core   +1 more source

An update on the use of indacaterol in patients with COPD

Therapeutic Advances in Respiratory Disease, 2011
Current guidelines for the management of chronic obstructive pulmonary disease (COPD) establish that bronchodilator medications are central to the symptomatic treatment of the disease.
Nadia S. Brienza, Óscar Amor-Carro, David Ramos-Barbón   +2 more
doaj   +1 more source

Efficacy of salmeterol/fluticasone propionate by GOLD stage of chronic obstructive pulmonary disease: analysis from the randomised, placebo-controlled TORCH study [PDF]

, 2009
Background: The efficacy of inhaled salmeterol plus fluticasone propionate (SFC) in patients with severe or very severe COPD is well documented. However, there are only limited data about the influence of GOLD severity staging on the effectiveness of ...
Jones, Paul W, Yates, Julie C, Jones, PW, Yates Julie C, Vestbo Jörgen, Jenkins, Christine R, Willits, LR, Celli Bartolome, Willits Lisa R, Anderson, Julie A., Calverley, PMA, Calverley, PM, Willits, Lisa R., Julie A Anderson, Jörgen Vestbo, Anderson Julie A, Yates, JC, Calverley Peter MA, Anderson, JA, Vestbo, Jörgen, Jones Paul W, Ferguson Gary T, Christine R Jenkins, Jenkins, CR, Ferguson, GT, Gary T Ferguson, Anderson, Julie A, Vestbo, Jorgen; id_orcid, Celli, Bartolome, Bartolome Celli, Peter MA Calverley, Lisa R Willits, Ferguson, Gary T., Calverley, Peter M A, Ferguson, Gary T, Vestbo, J, Jenkins Christine R, Jenkins, CR ; https://orcid.org/, Celli, B, Paul W Jones, Jones, Paul W., Jenkins, Christine R., Julie C Yates, Willits, Lisa R, Yates, Julie C.   +44 more
core   +2 more sources

Pharmacologic Therapies for Preventing Chronic Obstructive Pulmonary Disease Exacerbations: A Comprehensive Review [PDF]

Tuberculosis and Respiratory Diseases
Chronic obstructive pulmonary disease (COPD) is a progressive respiratory disorder characterized by acute exacerbations that accelerate disease progression, increase hospitalizations, and elevate mortality.
Hyun Woo Lee
doaj   +1 more source

Investigation of the assortment of medicines for the treatment of chronic obstructive pulmonary disease in the pharmaceutical market of Ukraine

Aktualʹnì Pitannâ Farmacevtičnoï ì Medičnoï Nauki ta Praktiki, 2020
The aim of the work – to analyze the assortment of medicines for the treatment of chronic obstructive pulmonary disease (COPD) (bronchodilator therapy (BT). in the modern pharmaceutical market of Ukraine. Materials and Methods.
L. I. Budniak , Ye. Yu. Dynia
doaj   +1 more source